These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 37925226)
1. Prevention of Rhesus-D Alloimmunization in the First Trimester of Pregnancy: Economic Analysis of Three Management Strategies. Dochez V; Chabernaud C; Schirr-Bonnans S; Riche VP; Thubert T; Winer N; Vigoureux S Transfus Med Rev; 2024 Jan; 38(1):150778. PubMed ID: 37925226 [TBL] [Abstract][Full Text] [Related]
3. [Prevention of Rh D alloimmunization in the first trimester of the pregnancy: French College of Obstetricians and Gynecologists guidelines for clinical practice]. Vigoureux S; Maurice P; Sibiude J; Garabedian C; Sananès N Gynecol Obstet Fertil Senol; 2024; 52(7-8):446-453. PubMed ID: 38417789 [TBL] [Abstract][Full Text] [Related]
5. Prevention of RhD alloimmunization in RhD negative women. Lubusky M Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2010 Mar; 154(1):3-7. PubMed ID: 20445704 [TBL] [Abstract][Full Text] [Related]
6. Guideline No. 448: Prevention of Rh D Alloimmunization. Fung-Kee-Fung K; Wong K; Walsh J; Hamel C; Clarke G J Obstet Gynaecol Can; 2024 Apr; 46(4):102449. PubMed ID: 38553007 [TBL] [Abstract][Full Text] [Related]
7. Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies. Tiblad E; Westgren M; Pasupathy D; Karlsson A; Wikman AT Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1079-85. PubMed ID: 23750781 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of the management of rh-negative pregnant women. Duplantie J; Gonzales OM; Bois A; Nshimyumukiza L; Gekas J; Bujold E; Morin V; Vallée M; Giguère Y; Gagné C; Rousseau F; Reinharz D J Obstet Gynaecol Can; 2013 Aug; 35(8):730-740. PubMed ID: 24007709 [TBL] [Abstract][Full Text] [Related]
9. Do Rh-negative women with first trimester spontaneous abortions need Rh immune globulin? Hannafin B; Lovecchio F; Blackburn P Am J Emerg Med; 2006 Jul; 24(4):487-9. PubMed ID: 16787810 [TBL] [Abstract][Full Text] [Related]
10. Practices for RhD alloimmunization prevention: a vignette-based survey of midwives. Jourdren G; Berveiller P; Rousseau A J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7629-7639. PubMed ID: 34433367 [TBL] [Abstract][Full Text] [Related]
11. Is Rh immune globulin needed in early first-trimester abortion? A review. Jabara S; Barnhart KT Am J Obstet Gynecol; 2003 Mar; 188(3):623-7. PubMed ID: 12634631 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women. Darlington M; Carbonne B; Mailloux A; Brossard Y; Levy-Mozziconacci A; Cortey A; Maoulida H; Simon T; Rousseau A; Durand-Zaleski I; BMC Pregnancy Childbirth; 2018 Dec; 18(1):496. PubMed ID: 30547830 [TBL] [Abstract][Full Text] [Related]
13. [Prevention of Rh (D) alloimmunization in Rh (D) negative women in pregnancy and after birth of Rh (D) positive infant]. L'ubuský M; Procházka M; Krejcová L; Vetr M; Santavý J; Kudela M Ceska Gynekol; 2006 May; 71(3):173-9. PubMed ID: 16768042 [TBL] [Abstract][Full Text] [Related]
14. Intramuscular versus intravenous anti-D for preventing Rhesus alloimmunization during pregnancy. Okwundu CI; Afolabi BB Cochrane Database Syst Rev; 2013 Jan; (1):CD007885. PubMed ID: 23440818 [TBL] [Abstract][Full Text] [Related]
15. Use of anti-D immunoglobulin in the treatment of threatened miscarriage in the accident and emergency department. Weinberg L Emerg Med J; 2001 Nov; 18(6):444-7. PubMed ID: 11696491 [TBL] [Abstract][Full Text] [Related]
16. [Guideline for prevention of RhD alloimmunization in RhD negative women]. Lubuský M; Procházka M; Simetka O; Holusková I Ceska Gynekol; 2010 Aug; 75(4):323-4. PubMed ID: 20925231 [TBL] [Abstract][Full Text] [Related]
17. ACOG practice bulletin. Prevention of Rh D alloimmunization. Number 4, May 1999 (replaces educational bulletin Number 147, October 1990). Clinical management guidelines for obstetrician-gynecologists. American College of Obstetrics and Gynecology. Int J Gynaecol Obstet; 1999 Jul; 66(1):63-70. PubMed ID: 10458556 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of first trimester non-invasive fetal RHD screening for targeted antenatal anti-D prophylaxis in RhD-negative pregnant women: a model-based analysis. Neovius M; Tiblad E; Westgren M; Kublickas M; Neovius K; Wikman A BJOG; 2016 Jul; 123(8):1337-46. PubMed ID: 26663771 [TBL] [Abstract][Full Text] [Related]
19. Prevention of Rh(D) alloimmunization: a cost-benefit analysis. Baskett TF; Parsons ML CMAJ; 1990 Feb; 142(4):337-9. PubMed ID: 2154307 [TBL] [Abstract][Full Text] [Related]
20. Rhesus D alloimmunization in pregnancy from 1996 to 2015 in Iceland: a nation-wide population study prior to routine antenatal anti-D prophylaxis. Gudlaugsson B; Hjartardottir H; Svansdottir G; Gudmundsdottir G; Kjartansson S; Jonsson T; Gudmundsson S; Halldorsdottir AM Transfusion; 2020 Jan; 60(1):175-183. PubMed ID: 31850521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]